CAS 733717-87-8

(2S)-5,5-Dimethyl-2-morpholineacetic acid

Description:

(2S)-5,5-Dimethyl-2-morpholineacetic acid is an organic compound characterized by its morpholine ring structure and a carboxylic acid functional group. This compound features a chiral center, which contributes to its stereochemistry, specifically the (2S) configuration. The presence of two methyl groups at the 5-position of the morpholine ring enhances its steric properties and may influence its biological activity. As a morpholine derivative, it may exhibit unique interactions with biological targets, making it of interest in medicinal chemistry. The carboxylic acid group is polar and can participate in hydrogen bonding, which may affect its solubility and reactivity. This compound is typically studied for its potential applications in pharmaceuticals, particularly in the development of drugs that target specific biological pathways. Its CAS number, 733717-87-8, provides a unique identifier for regulatory and research purposes, facilitating the tracking of its properties and applications in scientific literature. Overall, (2S)-5,5-Dimethyl-2-morpholineacetic acid is a compound of interest due to its structural features and potential utility in various chemical and biological contexts.

Formula: C₈H₁₅NO₃

InChI: InChI=1S/C8H15NO3/c1-8(2)5-12-6(4-9-8)3-7(10)11/h6,9H,3-5H2,1-2H3,(H,10,11)/t6-/m0/s1

InChI key: InChIKey=SEYCKMQSPUVYEF-LURJTMIESA-N

SMILES: C(C(O)=O)[C@H]1CNC(C)(C)CO1

Synonyms:

• 2-Morpholineacetic acid, 5,5-dimethyl-, (2S)-
• (2S)-5,5-Dimethyl-2-morpholineacetic acid

SCH 50911

Controlled Product

CAS: 733717-87-8

Formula: C₈H₁₅NO₃

Color and Shape: Neat

Molecular weight: 173.21

Ref: TR-S200045

SCH 50911

CAS: 733717-87-8

SCH 50911 is a potent antagonist of the 5-HT7 receptor, which is a G protein-coupled receptor. It has been shown to inhibit acetylcholine release in rat striatal tissue and to increase gamma-aminobutyric acid (GABA) levels in vitro. SCH 50911 also inhibits dopamine release in vitro and decreases locomotor activity in rats. These effects are thought to be due to the inhibition of acetylcholine release and decreased dopamine release. SCH 50911 has been clinically studied for its efficacy as a treatment for anxiety disorders and depression, but has not been approved for general use yet.

Formula: C₈H₁₅NO₃

Purity: Min. 95%

Molecular weight: 173.21 g/mol

Ref: 3D-IEB71787

SCH 50911

CAS: 733717-87-8

SCH 50911 is a selective GABA(B) receptor antagonist with IC50: 1.1 μM, boosting 3H overflow at IC50: 3 μM.

Formula: C₈H₁₅NO₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 173.21

Ref: TM-T12867L